Dr. Reddy's Laboratories Share Price
1208.00-3.20 (-0.26%)
-7.67% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
Dr. Reddy's Laboratories Share Price
1208.00-3.20 (-0.26%)
-7.67% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 8% | 12% | 11% | 3% |
| 7% | 17% | -2% | -27% |
| 7% | 5% | 3% | -7% |
| 14% | 17% | 17% | 12% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Less Impairment of Assets
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 | Mar 2006 | Mar 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹84 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹85 Cr | ₹85 Cr | ₹85 Cr | ₹85 Cr | ₹85 Cr | ₹85 Cr | ₹84 Cr | ₹84 Cr | ₹84 Cr | ₹84 Cr | ₹38 Cr | ₹38 Cr |
| ₹149 Cr | ₹145 Cr | ₹131 Cr | ₹146 Cr | ₹143 Cr | ₹127 Cr | ₹104 Cr | ₹80 Cr | ₹83 Cr | ₹80 Cr | ₹91 Cr | ₹91 Cr | ₹82 Cr | ₹69 Cr | ₹55 Cr | ₹41 Cr | ₹35 Cr | ₹39 Cr | ₹35 Cr | ₹23 Cr | ₹11 Cr | ₹5 Cr |
| ₹37659 Cr | ₹33322 Cr | ₹28040 Cr | ₹23057 Cr | ₹18986 Cr | ₹17432 Cr | ₹15412 Cr | ₹13861 Cr | ₹12406 Cr | ₹12099 Cr | ₹12394 Cr | ₹9677 Cr | ₹7699 Cr | ₹6215 Cr | ₹4849 Cr | ₹3907 Cr | ₹3657 Cr | ₹3403 Cr | ₹4378 Cr | ₹3891 Cr | ₹2019 Cr | ₹1898 Cr |
| ₹37659 Cr | ₹33322 Cr | ₹28040 Cr | ₹23057 Cr | ₹18986 Cr | ₹17432 Cr | ₹15412 Cr | ₹13861 Cr | ₹12406 Cr | ₹12099 Cr | ₹12394 Cr | ₹9677 Cr | ₹7699 Cr | ₹6215 Cr | ₹4849 Cr | ₹3907 Cr | ₹3657 Cr | ₹3403 Cr | ₹4378 Cr | ₹3891 Cr | ₹2019 Cr | ₹1898 Cr |
| ₹37892 Cr | ₹33550 Cr | ₹28255 Cr | ₹23286 Cr | ₹19212 Cr | ₹17642 Cr | ₹15599 Cr | ₹14024 Cr | ₹12572 Cr | ₹12262 Cr | ₹12570 Cr | ₹9853 Cr | ₹7865 Cr | ₹6369 Cr | ₹4989 Cr | ₹4032 Cr | ₹3777 Cr | ₹3526 Cr | ₹4497 Cr | ₹3997 Cr | ₹2069 Cr | ₹1942 Cr |
| ₹339 Cr | ₹378 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1 Cr | ₹0 | ₹0 |
| ₹1220 Cr | ₹406 Cr | ₹219 Cr | ₹128 Cr | ₹195 Cr | ₹250 Cr | ₹130 Cr | ₹55 Cr | ₹63 Cr | ₹60 Cr | ₹75 Cr | ₹78 Cr | ₹95 Cr | ₹80 Cr | ₹26 Cr | ₹24 Cr | ₹27 Cr | ₹39 Cr | ₹64 Cr | ₹614 Cr | ₹178 Cr | ₹10 Cr |
| ₹0 | ₹380 Cr | ₹380 Cr | ₹0 | ₹380 Cr | ₹380 Cr | ₹0 | ₹2145 Cr | ₹2446 Cr | ₹485 Cr | ₹994 Cr | ₹1354 Cr | ₹1981 Cr | ₹1186 Cr | ₹1616 Cr | ₹513 Cr | ₹1457 Cr | ₹1959 Cr | ₹1904 Cr | ₹1876 Cr | ₹2939 Cr | ₹270 Cr |
| -₹672 Cr | -₹429 Cr | -₹974 Cr | -₹629 Cr | -₹1276 Cr | -₹1040 Cr | -₹1218 Cr | -₹384 Cr | -₹346 Cr | -₹516 Cr | -₹537 Cr | -₹104 Cr | -₹68 Cr | -₹67 Cr | -₹115 Cr | -₹23 Cr | ₹7 Cr | ₹54 Cr | ₹81 Cr | ₹97 Cr | ₹75 Cr | ₹21 Cr |
| ₹344 Cr | ₹245 Cr | ₹314 Cr | ₹203 Cr | ₹167 Cr | ₹162 Cr | ₹206 Cr | ₹218 Cr | ₹293 Cr | ₹343 Cr | ₹250 Cr | ₹273 Cr | ₹118 Cr | ₹35 Cr | ₹50 Cr | ₹57 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹34 Cr | ₹30 Cr | ₹24 Cr | ₹20 Cr | ₹26 Cr | ₹51 Cr | ₹75 Cr | ₹79 Cr | ₹82 Cr | ₹84 Cr | ₹95 Cr | ₹78 Cr | ₹56 Cr | ₹51 Cr | ₹33 Cr | ₹29 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹926 Cr | ₹633 Cr | -₹37 Cr | -₹278 Cr | -₹508 Cr | -₹197 Cr | -₹808 Cr | ₹2113 Cr | ₹2538 Cr | ₹456 Cr | ₹877 Cr | ₹1678 Cr | ₹2182 Cr | ₹1285 Cr | ₹1610 Cr | ₹600 Cr | ₹1491 Cr | ₹2051 Cr | ₹2049 Cr | ₹2587 Cr | ₹3192 Cr | ₹301 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹3038 Cr | ₹2648 Cr | ₹2614 Cr | ₹2268 Cr | ₹2266 Cr | ₹1811 Cr | ₹1525 Cr | ₹1367 Cr | ₹1335 Cr | ₹1057 Cr | ₹907 Cr | ₹867 Cr | ₹893 Cr | ₹966 Cr | ₹757 Cr | ₹635 Cr | ₹1668 Cr | ₹1506 Cr | ₹1028 Cr | ₹980 Cr | ₹846 Cr | ₹475 Cr |
| ₹6491 Cr | ₹5503 Cr | ₹4775 Cr | ₹4698 Cr | ₹3661 Cr | ₹3338 Cr | ₹3512 Cr | ₹2821 Cr | ₹2411 Cr | ₹2340 Cr | ₹2409 Cr | ₹2624 Cr | ₹2021 Cr | ₹2120 Cr | ₹1749 Cr | ₹1329 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹20 Cr |
| ₹5914 Cr | ₹3805 Cr | ₹1272 Cr | ₹739 Cr | ₹2708 Cr | ₹2315 Cr | ₹1653 Cr | ₹1213 Cr | ₹2556 Cr | ₹4363 Cr | ₹2272 Cr | ₹2186 Cr | ₹2061 Cr | ₹1899 Cr | ₹1589 Cr | ₹1832 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹1305 Cr | ₹1078 Cr | ₹926 Cr | ₹867 Cr | ₹1131 Cr | ₹640 Cr | ₹524 Cr | ₹497 Cr | ₹592 Cr | ₹661 Cr | ₹759 Cr | ₹1144 Cr | ₹816 Cr | ₹674 Cr | ₹497 Cr | ₹413 Cr | ₹350 Cr | ₹199 Cr | ₹118 Cr | ₹138 Cr | ₹213 Cr | ₹186 Cr |
| ₹16747 Cr | ₹13034 Cr | ₹9588 Cr | ₹8572 Cr | ₹9766 Cr | ₹8104 Cr | ₹7214 Cr | ₹5897 Cr | ₹6894 Cr | ₹8420 Cr | ₹6347 Cr | ₹6821 Cr | ₹5790 Cr | ₹5659 Cr | ₹4591 Cr | ₹4209 Cr | ₹2025 Cr | ₹1711 Cr | ₹1151 Cr | ₹1123 Cr | ₹1066 Cr | ₹680 Cr |
| ₹55904 Cr | ₹47594 Cr | ₹37806 Cr | ₹31580 Cr | ₹28470 Cr | ₹25548 Cr | ₹22005 Cr | ₹22034 Cr | ₹22004 Cr | ₹21138 Cr | ₹19794 Cr | ₹18353 Cr | ₹15838 Cr | ₹13313 Cr | ₹11190 Cr | ₹8841 Cr | ₹7293 Cr | ₹7289 Cr | ₹7697 Cr | ₹7709 Cr | ₹6327 Cr | ₹2923 Cr |
| ₹336 Cr | ₹83 Cr | ₹109 Cr | ₹107 Cr | ₹108 Cr | ₹96 Cr | ₹177 Cr | ₹167 Cr | ₹335 Cr | ₹261 Cr | ₹440 Cr | ₹465 Cr | ₹412 Cr | ₹174 Cr | ₹92 Cr | ₹139 Cr | ₹90 Cr | ₹104 Cr | ₹1504 Cr | ₹228 Cr | ₹160 Cr | ₹252 Cr |
| ₹7734 Cr | ₹4677 Cr | ₹2002 Cr | ₹1347 Cr | ₹3385 Cr | ₹3031 Cr | ₹2210 Cr | ₹3838 Cr | ₹5071 Cr | ₹4919 Cr | ₹3351 Cr | ₹4314 Cr | ₹4477 Cr | ₹3682 Cr | ₹3234 Cr | ₹2371 Cr | ₹1484 Cr | ₹1998 Cr | ₹1968 Cr | ₹2491 Cr | ₹3117 Cr | ₹280 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹43854 Cr | ₹36760 Cr | ₹24527 Cr | ₹25567 Cr | ₹23096 Cr | ₹21887 Cr | ₹19336 Cr | ₹18048 Cr | ₹17436 Cr | ₹15932 Cr | ₹15020 Cr | ₹12574 Cr | ₹11918 Cr | ₹10089 Cr | ₹8842 Cr | ₹7975 Cr | ₹6447 Cr | ₹6503 Cr | ₹5488 Cr | ₹4720 Cr | ₹4201 Cr | ₹1305 Cr |
| ₹21494 Cr | ₹18533 Cr | ₹14101 Cr | ₹16348 Cr | ₹14895 Cr | ₹13632 Cr | ₹12485 Cr | ₹10857 Cr | ₹10468 Cr | ₹9002 Cr | ₹8457 Cr | ₹7170 Cr | ₹7277 Cr | ₹5985 Cr | ₹5295 Cr | ₹4590 Cr | ₹4095 Cr | ₹2113 Cr | ₹1575 Cr | ₹1185 Cr | ₹810 Cr | ₹525 Cr |
| ₹297 Cr | ₹0 | ₹50 L | ₹0 | ₹80 Cr | ₹49 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹27 Cr | ₹0 | ₹54 Cr | ₹135 Cr | ₹0 | ₹0 | ₹1463 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹22063 Cr | ₹18226 Cr | ₹10426 Cr | ₹9219 Cr | ₹8122 Cr | ₹8206 Cr | ₹6850 Cr | ₹7191 Cr | ₹6968 Cr | ₹6931 Cr | ₹6563 Cr | ₹5377 Cr | ₹4641 Cr | ₹4051 Cr | ₹3412 Cr | ₹3386 Cr | ₹2352 Cr | ₹2927 Cr | ₹3913 Cr | ₹3535 Cr | ₹3392 Cr | ₹780 Cr |
| ₹1460 Cr | ₹2399 Cr | ₹1351 Cr | ₹975 Cr | ₹1280 Cr | ₹954 Cr | ₹436 Cr | ₹473 Cr | ₹768 Cr | ₹610 Cr | ₹663 Cr | ₹529 Cr | ₹639 Cr | ₹565 Cr | ₹709 Cr | ₹575 Cr | ₹762 Cr | ₹430 Cr | ₹268 Cr | ₹290 Cr | ₹140 Cr | ₹62 Cr |
| ₹1612 Cr | ₹721 Cr | ₹526 Cr | ₹536 Cr | ₹593 Cr | ₹833 Cr | ₹309 Cr | ₹334 Cr | ₹465 Cr | ₹683 Cr | ₹330 Cr | ₹146 Cr | ₹40 L | ₹40 L | ₹90 L | ₹90 L | ₹60 L | ₹60 L | ₹131 Cr | ₹133 Cr | ₹132 Cr | ₹102 Cr |
| ₹1612 Cr | ₹721 Cr | ₹526 Cr | ₹536 Cr | ₹593 Cr | ₹833 Cr | ₹309 Cr | ₹334 Cr | ₹465 Cr | ₹683 Cr | ₹330 Cr | ₹146 Cr | ₹40 L | ₹40 L | ₹90 L | ₹90 L | ₹60 L | ₹60 L | ₹131 Cr | ₹133 Cr | ₹132 Cr | ₹102 Cr |
| ₹507 Cr | ₹341 Cr | ₹542 Cr | ₹356 Cr | ₹452 Cr | ₹377 Cr | ₹689 Cr | ₹427 Cr | ₹565 Cr | ₹482 Cr | ₹290 Cr | ₹418 Cr | ₹232 Cr | ₹149 Cr | ₹70 Cr | ₹64 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹234 Cr | ₹822 Cr | ₹89 Cr | ₹13 Cr | ₹222 Cr | ₹17 Cr | ₹23 Cr | ₹38 Cr | ₹37 Cr | ₹35 Cr | ₹44 Cr | ₹6 Cr | ₹0 | ₹21 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹25876 Cr | ₹22576 Cr | ₹13001 Cr | ₹11155 Cr | ₹10682 Cr | ₹10998 Cr | ₹9406 Cr | ₹10924 Cr | ₹11505 Cr | ₹11454 Cr | ₹8000 Cr | ₹6476 Cr | ₹5512 Cr | ₹4786 Cr | ₹4191 Cr | ₹4026 Cr | ₹3115 Cr | ₹3357 Cr | ₹4312 Cr | ₹3958 Cr | ₹3664 Cr | ₹943 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹3673 Cr | ₹3331 Cr | ₹4405 Cr | ₹4450 Cr | ₹2023 Cr | ₹1379 Cr | ₹2369 Cr | ₹2253 Cr | ₹1833 Cr | ₹1427 Cr | ₹3503 Cr | ₹2102 Cr | ₹1066 Cr | ₹197 Cr | ₹207 Cr | ₹0 | ₹357 Cr | ₹52 Cr | ₹351 Cr | ₹2 Cr | ₹1 Cr | ₹30 Cr |
| ₹7653 Cr | ₹7109 Cr | ₹6355 Cr | ₹4867 Cr | ₹5088 Cr | ₹4541 Cr | ₹3507 Cr | ₹3358 Cr | ₹2909 Cr | ₹2853 Cr | ₹2558 Cr | ₹2570 Cr | ₹2419 Cr | ₹2171 Cr | ₹1943 Cr | ₹1599 Cr | ₹1339 Cr | ₹1325 Cr | ₹1102 Cr | ₹747 Cr | ₹667 Cr | ₹353 Cr |
| ₹10123 Cr | ₹9042 Cr | ₹8030 Cr | ₹7249 Cr | ₹6676 Cr | ₹4964 Cr | ₹5028 Cr | ₹3987 Cr | ₹4053 Cr | ₹3799 Cr | ₹4125 Cr | ₹4101 Cr | ₹3325 Cr | ₹3180 Cr | ₹2537 Cr | ₹1761 Cr | ₹1160 Cr | ₹1441 Cr | ₹652 Cr | ₹781 Cr | ₹510 Cr | ₹382 Cr |
| ₹3349 Cr | ₹2460 Cr | ₹1728 Cr | ₹1730 Cr | ₹2419 Cr | ₹2079 Cr | ₹205 Cr | ₹223 Cr | ₹264 Cr | ₹387 Cr | ₹492 Cr | ₹1872 Cr | ₹2301 Cr | ₹2017 Cr | ₹1606 Cr | ₹575 Cr | ₹660 Cr | ₹562 Cr | ₹745 Cr | ₹1861 Cr | ₹980 Cr | ₹935 Cr |
| ₹1183 Cr | ₹1072 Cr | ₹1011 Cr | ₹1204 Cr | ₹737 Cr | ₹850 Cr | ₹1046 Cr | ₹850 Cr | ₹766 Cr | ₹452 Cr | ₹393 Cr | ₹226 Cr | ₹170 Cr | ₹165 Cr | ₹94 Cr | ₹116 Cr | ₹2 Cr | ₹70 L | ₹3 Cr | ₹56 L | ₹0 | ₹2 Cr |
| ₹4047 Cr | ₹2004 Cr | ₹3276 Cr | ₹927 Cr | ₹844 Cr | ₹723 Cr | ₹445 Cr | ₹440 Cr | ₹674 Cr | ₹767 Cr | ₹723 Cr | ₹1005 Cr | ₹1044 Cr | ₹797 Cr | ₹612 Cr | ₹763 Cr | ₹659 Cr | ₹551 Cr | ₹532 Cr | ₹359 Cr | ₹505 Cr | ₹278 Cr |
| ₹30029 Cr | ₹25018 Cr | ₹24805 Cr | ₹20425 Cr | ₹17788 Cr | ₹14535 Cr | ₹12599 Cr | ₹11110 Cr | ₹10498 Cr | ₹9684 Cr | ₹11794 Cr | ₹11877 Cr | ₹10326 Cr | ₹8527 Cr | ₹6999 Cr | ₹4815 Cr | ₹4178 Cr | ₹3932 Cr | ₹3385 Cr | ₹3751 Cr | ₹2663 Cr | ₹1980 Cr |
| ₹13281 Cr | ₹11984 Cr | ₹15217 Cr | ₹11853 Cr | ₹8022 Cr | ₹6431 Cr | ₹5385 Cr | ₹5213 Cr | ₹3605 Cr | ₹1264 Cr | ₹5447 Cr | ₹5055 Cr | ₹4535 Cr | ₹2868 Cr | ₹2408 Cr | ₹607 Cr | ₹2153 Cr | ₹2220 Cr | ₹2234 Cr | ₹2628 Cr | ₹1597 Cr | ₹1300 Cr |
| ₹55904 Cr | ₹47594 Cr | ₹37806 Cr | ₹31580 Cr | ₹28470 Cr | ₹25548 Cr | ₹22005 Cr | ₹22034 Cr | ₹22004 Cr | ₹21138 Cr | ₹19794 Cr | ₹18353 Cr | ₹15838 Cr | ₹13313 Cr | ₹11190 Cr | ₹8841 Cr | ₹7293 Cr | ₹7289 Cr | ₹7697 Cr | ₹7709 Cr | ₹6327 Cr | ₹2923 Cr |
| ₹452 | ₹401 | ₹1,686 | ₹1,389 | ₹1,146 | ₹1,053 | ₹932 | ₹840 | ₹752 | ₹735 | ₹731 | ₹573 | ₹457 | ₹371 | ₹291 | ₹236 | ₹222 | ₹207 | ₹265 | ₹237 | ₹268 | ₹253 |
| ₹452 | ₹401 | ₹337 | ₹278 | ₹1,146 | ₹1,053 | ₹932 | ₹840 | ₹752 | ₹735 | ₹731 | ₹573 | ₹457 | ₹74 | ₹291 | ₹236 | ₹222 | ₹207 | ₹265 | ₹237 | ₹134 | ₹127 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 | Mar 2006 | Mar 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹5393 Cr | ₹7680 Cr | ₹7201 Cr | ₹6049 Cr | ₹3061 Cr | ₹2884 Cr | ₹1886 Cr | ₹2336 Cr | ₹1350 Cr | ₹1554 Cr | ₹2859 Cr | ₹2900 Cr | ₹2646 Cr | ₹2165 Cr | ₹1804 Cr | ₹1183 Cr | ₹618 Cr | -₹656 Cr | ₹545 Cr | ₹1240 Cr | ₹201 Cr | ₹14 Cr |
| ₹2708 Cr | ₹1962 Cr | ₹1365 Cr | ₹1696 Cr | ₹2334 Cr | ₹2087 Cr | ₹2563 Cr | ₹835 Cr | ₹1625 Cr | ₹1687 Cr | ₹1108 Cr | ₹1654 Cr | ₹1043 Cr | ₹1063 Cr | ₹1157 Cr | ₹530 Cr | ₹1117 Cr | ₹2080 Cr | ₹523 Cr | ₹499 Cr | ₹160 Cr | ₹112 Cr |
| -₹1075 Cr | -₹2999 Cr | -₹2018 Cr | -₹786 Cr | -₹1841 Cr | -₹829 Cr | -₹754 Cr | ₹184 Cr | -₹897 Cr | -₹520 Cr | -₹3 Cr | -₹1484 Cr | -₹1005 Cr | -₹1294 Cr | -₹894 Cr | -₹659 Cr | -₹138 Cr | -₹546 Cr | -₹402 Cr | -₹297 Cr | -₹231 Cr | ₹100 Cr |
| ₹7026 Cr | ₹6642 Cr | ₹6548 Cr | ₹6959 Cr | ₹3555 Cr | ₹4142 Cr | ₹3695 Cr | ₹3355 Cr | ₹2079 Cr | ₹2721 Cr | ₹3964 Cr | ₹3070 Cr | ₹2684 Cr | ₹1933 Cr | ₹2068 Cr | ₹1054 Cr | ₹1598 Cr | ₹878 Cr | ₹666 Cr | ₹1442 Cr | ₹130 Cr | ₹226 Cr |
| ₹5674 Cr | ₹4643 Cr | ₹4543 Cr | ₹5888 Cr | ₹2811 Cr | ₹3570 Cr | ₹2984 Cr | ₹2870 Cr | ₹1803 Cr | ₹2144 Cr | ₹3263 Cr | ₹2524 Cr | ₹1970 Cr | ₹1378 Cr | ₹1613 Cr | ₹755 Cr | ₹1315 Cr | ₹599 Cr | ₹513 Cr | ₹1259 Cr | ₹110 Cr | ₹230 Cr |
| -₹6549 Cr | -₹5808 Cr | -₹4028 Cr | -₹4137 Cr | -₹2639 Cr | -₹2266 Cr | -₹492 Cr | -₹773 Cr | -₹1488 Cr | -₹1840 Cr | -₹2039 Cr | -₹2265 Cr | -₹1694 Cr | -₹1446 Cr | -₹1888 Cr | -₹899 Cr | -₹710 Cr | -₹505 Cr | -₹810 Cr | -₹415 Cr | -₹2761 Cr | ₹94 Cr |
| ₹829 Cr | ₹1891 Cr | -₹376 Cr | -₹2686 Cr | -₹242 Cr | -₹30 Cr | -₹2516 Cr | -₹2133 Cr | -₹444 Cr | -₹369 Cr | -₹1700 Cr | -₹433 Cr | -₹24 Cr | -₹157 Cr | ₹389 Cr | ₹45 Cr | -₹532 Cr | -₹265 Cr | -₹775 Cr | ₹23 Cr | ₹2688 Cr | ₹158 Cr |
| -₹47 Cr | ₹726 Cr | ₹139 Cr | -₹936 Cr | -₹70 Cr | ₹1275 Cr | -₹24 Cr | -₹35 Cr | -₹129 Cr | -₹65 Cr | -₹477 Cr | -₹174 Cr | ₹251 Cr | -₹225 Cr | ₹113 Cr | -₹99 Cr | ₹73 Cr | -₹171 Cr | -₹1073 Cr | ₹867 Cr | ₹38 Cr | ₹482 Cr |
| ₹1459 Cr | ₹711 Cr | ₹578 Cr | ₹1485 Cr | ₹1482 Cr | ₹196 Cr | ₹223 Cr | ₹254 Cr | ₹378 Cr | ₹492 Cr | ₹540 Cr | ₹862 Cr | ₹520 Cr | ₹736 Cr | ₹573 Cr | ₹660 Cr | ₹562 Cr | ₹745 Cr | ₹1861 Cr | ₹980 Cr | ₹935 Cr | ₹450 Cr |
| ₹124 Cr | ₹22 Cr | -₹6 Cr | ₹29 Cr | ₹73 Cr | ₹11 Cr | -₹3 Cr | ₹4 Cr | ₹6 Cr | -₹49 Cr | ₹430 Cr | -₹105 Cr | ₹91 Cr | ₹9 Cr | ₹50 Cr | ₹14 Cr | ₹25 Cr | -₹11 Cr | -₹43 Cr | ₹14 Cr | ₹7 Cr | ₹4 Cr |
| ₹1537 Cr | ₹1459 Cr | ₹711 Cr | ₹578 Cr | ₹1485 Cr | ₹1482 Cr | ₹196 Cr | ₹223 Cr | ₹254 Cr | ₹378 Cr | ₹492 Cr | ₹583 Cr | ₹862 Cr | ₹520 Cr | ₹736 Cr | ₹575 Cr | ₹660 Cr | ₹562 Cr | ₹745 Cr | ₹1861 Cr | ₹980 Cr | ₹935 Cr |
Fundamental Ratios
Consolidated
Standalone
Dr. Reddy's Laboratories Share Price
1208.00-3.20 (-0.26%)
-7.67% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 6 out of 9 oscillators
RSI
60.44Buy
STOCH %K
84.78Sell
MACD Level(12,26)
5.15Buy
Ultimate Oscillator
48.18Sell
Aroon Oscillator
-12.00Sell
BOP
-0.31Sell
CCI
131.61Sell
Williams %R
-15.22Sell
Momentum
53.00Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 7
Bearish signals: 2 out of 9 moving averages
EMA 9
1188.89Buy
SMA 9
1182.11Buy
EMA 21
1178.48Buy
SMA 21
1168.91Buy
EMA 50
1191.01Buy
SMA 50
1175.09Buy
EMA 200
1232.74Sell
SMA 200
1248.18Sell
WMA 20
1174.97Buy
Pivot
Pivot
Classic
Resistance 5
1270.93
Resistance 4
1256.33
Resistance 3
1241.73
Resistance 2
1227.13
Resistance 1
1219.17
Pivot
1212.53
Support 1
1204.57
Support 2
1197.93
Support 3
1183.33
Support 4
1168.73
Support 5
1154.13
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Dr. Reddy's Laboratories Share Price
1208.00-3.20 (-0.26%)
-7.67% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 26.64% | 26.63% | 26.64% | 26.64% | 26.64% | 26.64% |
| 20.66% | 21.14% | 22.34% | 24.69% | 25.33% | 25.75% |
| 18.59% | 17.53% | 16.57% | 14.68% | 13.12% | 12.74% |
| 13.16% | 13.19% | 13.87% | 13.31% | 13.61% | 12.89% |
| 20.95% | 21.51% | 20.58% | 20.68% | 21.30% | 21.98% |
Bulk & block deals
Name
Kapitalforeningen Investin Pro
Kapitalforeningen Pensam Invest
The Mtbj Ltd. As Trst For Government Pension Investment Fund Mtbj400045849
The Mtbj Ltd. As Trst For Govrnmnt Pension Invstmnt Fund Mtbj400045828
Bofa Securities Europe Sa
Bofa Securities Europe Sa
The Jupiter Global Fund-Jupiter India Select
Jupiter South Asia Investment Company Limited
Aia Vcc - Aia Asian Equity Fund
Aia Investment Trust-Aia Singapore Participating Fund Sgd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 09 Sep 2025 | Purchase | 72.69 Cr | ₹1,250.60 | 5.81 L | Block | 0.06964 | NSE |
| 09 Sep 2025 | Sell | 72.69 Cr | ₹1,250.60 | 5.81 L | Block | 0.06964 | NSE |
| 14 Jul 2025 | Purchase | 17.76 Cr | ₹1,254 | 1.42 L | Block | 0.016965 | NSE |
| 14 Jul 2025 | Sell | 17.76 Cr | ₹1,254 | 1.42 L | Block | 0.016965 | NSE |
| 26 Mar 2024 | Purchase | 160.81 Cr | ₹6,184.85 | 2.60 L | Block | 0.03115 | BSE |
| 26 Mar 2024 | Sell | 160.81 Cr | ₹6,184.85 | 2.60 L | Block | 0.03115 | BSE |
| 18 Jan 2024 | Purchase | 18.01 Cr | ₹5,645.45 | 31.91 K | Block | 0.003823 | BSE |
| 18 Jan 2024 | Sell | 18.01 Cr | ₹5,645.45 | 31.91 K | Block | 0.003823 | BSE |
| 26 Oct 2023 | Purchase | 10.86 Cr | ₹5,355.20 | 20.27 K | Block | 0.002429 | BSE |
| 26 Oct 2023 | Sell | 9.35 Cr | ₹5,355.20 | 17.46 K | Block | 0.002091 | BSE |
Insider trading & SAST
Client name
Icici Prudential Mutual Fund
Tricia Wetzel
Patrick Aghanian
Patrick Aghanian
Swarna Rallabandi
Zachary Mcclard
C Swaminathan
C Swaminathan
Zachary Mcclard
Tricia Wetzel
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 Aug 2026 | Other | Acquisition | 0.08 | 5.03 | 0 | — | 7.13 L | 12 Aug 2026 | Market | 4,20,45,639 | SAST | 29(1) | — |
| 23 Jun 2026 | Designated Person | Acquisition | 0.000512 | 0 | 54.20 L | ₹1,267.80 | 4.28 K | 19 Jun 2026 | ESOP | 5,550 | Insider Trading | — | Any other instrument |
| 30 Mar 2026 | Designated Person | Acquisition | 0.00044 | 0 | 47.84 L | ₹1,301.90 | 3.67 K | 26 Mar 2026 | ESOP | 8,450 | Insider Trading | — | Any other instrument |
| 30 Mar 2026 | Designated Person | Acquisition | 0.00044 | 0 | 47.84 L | ₹1,301.90 | 3.67 K | 26 Mar 2026 | ESOP | 8,450 | Insider Trading | — | Any other instrument |
| 16 Mar 2026 | Designated Person | Acquisition | 0.000479 | 0 | 53.02 L | ₹1,325.50 | 4 K | 12 Mar 2026 | ESOP | 4,000 | Insider Trading | — | Any other instrument |
| 19 Feb 2026 | Designated Person | Acquisition | 0.000144 | 0 | 15.24 L | ₹1,269.60 | 1.20 K | 17 Feb 2026 | ESOP | 1,200 | Insider Trading | — | Any other instrument |
| 19 Feb 2026 | Designated Person | Acquisition | 0.000905 | 0 | 95.85 L | ₹1,269.60 | 7.55 K | 17 Feb 2026 | ESOP | 7,954 | Insider Trading | — | Any other instrument |
| 19 Feb 2026 | Designated Person | Acquisition | 0.000905 | 0 | 95.85 L | ₹1,269.60 | 7.55 K | 17 Feb 2026 | ESOP | 7,954 | Insider Trading | — | Any other instrument |
| 19 Feb 2026 | Designated Person | Acquisition | 0.000144 | 0 | 15.24 L | ₹1,269.60 | 1.20 K | 17 Feb 2026 | ESOP | 1,200 | Insider Trading | — | Any other instrument |
| 11 Dec 2025 | Designated Person | Acquisition | 0.000512 | 0 | 54.17 L | ₹1,267.15 | 4.28 K | 09 Dec 2025 | ESOP | 4,275 | Insider Trading | — | Any other instrument |
Dr. Reddy's Laboratories Share Price
1208.00-3.20 (-0.26%)
-7.67% past 1 Year
Dr. Reddy’s Laboratories is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global
Corporate Actions
Date
Type
Details
Company details
Dr. Reddy's Laboratories Share Price
1208.00-3.20 (-0.26%)
-7.67% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Dr. Reddy's Laboratories Share Price
1208.00-3.20 (-0.26%)
-7.67% past 1 Year
News
Dr Reddy’s plans analyst and investor meet on September 25
Equity
DRREDDY
Dr. Reddy’S Labs: Takeda And Co. Team Up To Market Qdenga, India’S First Approved Dengue Vaccine For Kids And Adults.
Equity
DRREDDY
Dr Reddy's Labs signs Gilead licensing deal for once yearly Lenacapavir HIV prevention
Equity
DRREDDY
Dr Reddy’s signs royalty-free HIV lenacapavir licence deal with Gilead
Equity
DRREDDY
Dr Reddy’s Labs gets USFDA observations at Mexico formulation facility
Equity
DRREDDY
Regulator plans clearer synthetic versus biological drug labelling norms for DRREDDY
Equity
DRREDDY
Dr Reddys Laboratories sees Rs 76.02 crore block trade on BSE
Equity
DRREDDY
India drafts uniform semaglutide manufacturing and testing standards for pharma
Equity
DRREDDY
HC cancels Razenta Pharma’s Daplogin trademark following Dr Reddy’s plea
Equity
DRREDDY
Dr. Reddys Laboratories sees Rs 48.95 Crores NSE block trade
Equity
DRREDDY
Dr. Reddys launches first generic Sugammadex injection in the US market
Equity
DRREDDY
Dr. Reddy’s gets US FDA approval for rituximab biosimilar
Equity
DRREDDY
Dr Reddy'S sees improved Q3, Q4 after resolving semaglutide issues
Equity
DRREDDY
Dr Reddy's gets Thai FDA approval for Nuzolvance zolifloxacin
Equity
DRREDDY
Dr Reddy's sees Rs 24.06 crores NSE block trade at set price level
Equity
DRREDDY
Dr Reddy's Laboratories plans 27 US product launches this year
Equity
DRREDDY
Dr Reddys biologics unit targets profitability with US abatacept launch
Equity
DRREDDY
Dr Reddy’s trims capex guidance, focuses on biosimilars and peptides investments
Equity
DRREDDY
Dr Reddy's Laboratories commentary on normalized full-year effective tax rate guidance
Equity
DRREDDY
Dr Reddy'S Labs guides higher long-term R&D spend at 7 to 8 percent of revenues
Equity
DRREDDY

